This page shows the details of why an item matched the keywords from your search.
| Item Type | Name |
|
Concept
|
Indoles
|
|
Academic Article
|
Statin trials in progress: unanswered questions.
|
|
Academic Article
|
The cost of reaching National Cholesterol Education Program (NCEP) goals in hypercholesterolaemic patients. A comparison of atorvastatin, simvastatin, lovastatin and fluvastatin.
|
|
Academic Article
|
A multicenter, randomized, double-blind clinical trial comparing the low-density lipoprotein cholesterol-lowering ability of lovastatin 10, 20, and 40 mg/d with fluvastatin 20 and 40 mg/d.
|
|
Academic Article
|
Extended-release niacin/laropiprant: reducing niacin-induced flushing to better realize the benefit of niacin in improving cardiovascular risk factors.
|
|
Academic Article
|
Novel nonstatin strategies to lower low-density lipoprotein cholesterol.
|
|
Academic Article
|
Considerations in the treatment of dyslipidemia associated with chronic kidney failure and renal transplantation.
|
|
Academic Article
|
Flushing profile of extended-release niacin/laropiprant versus gradually titrated niacin extended-release in patients with dyslipidemia with and without ischemic cardiovascular disease.
|
|
Academic Article
|
Fluvastatin administration at bedtime versus with the evening meal: a multicenter comparison of bioavailability, safety, and efficacy.
|
|
Academic Article
|
Effects of laropiprant on nicotinic acid-induced flushing in patients with dyslipidemia.
|
|
Academic Article
|
Fluvastatin Long-Term Extension Trial (FLUENT): summary of efficacy and safety.
|
|
Academic Article
|
Lipid-altering efficacy and safety profile of co-administered extended release niacin/laropiprant and simvastatin versus atorvastatin in patients with mixed hyperlipidemia.
|
|
Academic Article
|
Cognitive Effects of MIN-101 in Patients With Schizophrenia and Negative Symptoms: Results From a Randomized Controlled Trial.
|
|
Academic Article
|
Efficacy and Safety of MIN-101: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial of a New Drug in Development for the Treatment of Negative Symptoms in Schizophrenia.
|
|
Academic Article
|
Personal and social adjustment effects of roluperidone in patients with schizophrenia and negative symptoms: Results from an exploratory outcome of a randomized placebo-controlled trial.
|
|
Academic Article
|
The brief negative symptom scale (BNSS): Sensitivity to treatment effects.
|